Correlation between Methylation of Human Papillomavirus-16 L1 Gene and Cervical Carcinoma in Uyghur Women

Gynecologic and Obstetric Investigation

Volumn 82, Issue 1, 2017, Pages 22-29

  Niyazi, Mayineur ^a   Sui, Shuang ^a   Zhu, Kaichun ^a   Wang, Lin ^a   Jiao, Zhen ^a   Lu, Ping ^a  

^a PEOPLE S HOSPITAL OF XINJIANG UYGUR AUTONOMOUS REGION   (China)

Author keywords

Cervical cancer; L1; Methylation; Pyrosequencing; Uyghur women

Indexed keywords

ADULT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; CPG ISLAND; DNA ISOLATION; DNA METHYLATION; FEMALE; FOLLOW UP; GENE AMPLIFICATION; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; PAPILLOMAVIRUS INFECTION; PERSISTENT INFECTION; PRIORITY JOURNAL; PYROSEQUENCING; RECEIVER OPERATING CHARACTERISTIC; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UYGUR (PEOPLE); ASIAN CONTINENTAL ANCESTRY GROUP; GENETIC EPIGENESIS; GENETICS; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; PROSPECTIVE STUDY; UTERINE CERVIX TUMOR;

TUMOR MARKER; VIRUS DNA;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BIOMARKERS, TUMOR; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA METHYLATION; DNA, VIRAL; EPIGENESIS, GENETIC; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS;

EID: 84961221562     PISSN: 03787346     EISSN: 1423002X     Source Type: Journal    
DOI: 10.1159/000444585     Document Type: Article

References (30)

1. Pisani P, Bray F, Parkin DM: Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer 2002; 97: 72-81.
2. Word Health Organization: World Cancer Report 2014. WHO Report. Geneva, WHO, 2014, Chapter 5.12.
3. Word Health Organization: World Cancer Report 2014. WHO Report. Geneva, WHO, 2014, Chapter 1.1.
4. Zhao F, Hu SY, Zhang SW, Chen WQ, Qiao YL: [Cervical cancer mortality in 2004-2005 and changes during last 30 years in China]. Zhonghua Yu Fang Yi Xue Za Zhi 2010; 44: 408-412.
5. Globocan IARC: Estimated Cancer Incidence, Moratity and Prevalence Worldwide in 2012. http://globocan.iarc.fr/Pages/fact- sheets-population.aspx.
6. Chen Z, Ding J, Pang N, Du R, Meng W, Zhu Y, et al: The Th17/Treg balance and the expression of related cytokines in Uygur cervical cancer patients. Diagn Pathol 2013; 8: 61.
7. Koshiol J, Lindsay L, Pimenta JM, Poole C, Jenkins D, Smith JS: Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis. Am J Epidemiol 2008; 168: 123-137.
8. Louvanto K, Franco EL, Ramanakumar AV, Vasiljevi? N, Scibior-Bentkowska D, Koushik A, et al: Methylation of viral and host genes and severity of cervical lesions associated with human papillomavirus type 16. Int J Cancer 2015; 136:E638-E645.
9. Li N, Franceschi S, Howell-Jones R, Snijders PJ, Clifford GM: Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication. Int J Cancer 2011; 128: 927-935.
10. Rositch AF, Koshiol J, Hudgens MG, Razzaghi H, Backes DM, Pimenta JM, et al: Patterns of persistent genital human papillomavirus infection among women worldwide: a literature review and meta-analysis. Int J Cancer 2013; 133: 1271-1285.
11. Brandsma JL, Sun Y, Lizardi PM, Tuck DP, Zelterman D, Haines GK 3rd, et al: Distinct human papillomavirus type 16 methylomes in cervical cells at different stages of premalignancy. Virology 2009; 389: 100-107.
12. Kalantari M, Osann K, Calleja-Macias IE, Kim S, Yan B, Jordan S, et al: Methylation of human papillomavirus 16, 18, 31, and 45 L2 and L1 genes and the cellular DAPK gene: considerations for use as biomarkers of the progression of cervical neoplasia. Virology 2014; 448: 314-321.
13. Lorincz AT, Brentnall AR, Vasiljevi? N, Scibior-Bentkowska D, Castanon A, Fiander A, et al: HPV16 L1 and L2 DNA methylation predicts high-grade cervical intraepithelial neoplasia in women with mildly abnormal cervical cytology. Int J Cancer 2013; 133: 637-644.
14. Sun C, Reimers LL, Burk RD: Methylation of HPV16 genome CpG sites is associated with cervix precancer and cancer. Gynecol Oncol 2011; 121: 59-63.
15. Hesselink AT, Heideman DA, Steenbergen RD, Coupé VM, Overmeer RM, Rijkaart D, et al: Combined promoter methylation analysis of CADM1 and MAL: an objective triage tool for high-risk human papillomavirus DNApositive women. Clin Cancer Res 2011; 17: 2459-2465.
16. Oka N, Kajita M, Nishimura R, Ohbayashi C, Sudo T: L1 gene methylation in high-risk human papillomaviruses for the prognosis of cervical intraepithelial neoplasia. Int J Gynecol Cancer 2013; 23: 235-243.
17. Fernandez AF, Rosales C, Lopez-Nieva P, Graña O, Ballestar E, Ropero S, et al: The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer. Genome Res 2009; 19: 438-451.
18. Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinsky SM: Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 1989; 7: 209-214.
19. Mirabello L, Sun C, Ghosh A, Rodriguez AC, Schiffman M, Wentzensen N, et al: Methylation of human papillomavirus type 16 genome and risk of cervical precancer in a Costa Rican population. J Natl Cancer Inst 2012; 104: 556-565.
20. Kjellberg L, Hallmans G, Ahren AM, Johansson R, Bergman F, Wadell G, et al: Smoking, diet, pregnancy and oral contraceptive use as risk factors for cervical intra-epithelial neoplasia in relation to human papillomavirus infection. Br J Cancer 2000; 82: 1332-1338.
21. Louie K, de Sanjose S, Diaz M, Castellsagué X, Herrero R, Meijer CJ, et al: Early age at first sexual intercourse and early pregnancy are risk factors for cervical cancer in developing countries. Br J Cancer 2009; 100: 1191-1197.
22. Lie AK, Kristensen G: Human papillomavirus E6/E7 mRNA testing as a predictive marker for cervical carcinoma. Expert Rev Mol Diagn 2008; 8: 405-415.
23. Clarke MA, Wentzensen N, Mirabello L, Ghosh A, Wacholder S, Harari A, et al: Human papillomavirus DNA methylation as a potential biomarker for cervical cancer. Cancer Epidemiol Biomarkers Prev 2012; 21: 2125-2137.
24. Esteller M: Epigenetics in cancer. N Engl J Med 2008; 358: 1148-1159.
25. Kalantari M, Calleja-Macias IE, Tewari D, Hagmar B, Lie K, Barrera-Saldana HA, et al: Conserved methylation patterns of human papillomavirus type 16 DNA in asymptomatic infection and cervical neoplasia. J Virol 2004; 78: 12762-12772.
26. Kalantari M, Garcia-Carranca A, Morales-Vazquez CD, Zuna R, Montiel DP, Calleja-Macias IE, et al: Laser capture microdissection of cervical human papillomavirus infections: copy number of the virus in cancerous and normal tissue and heterogeneous DNA methylation. Virology 2009; 390: 261-267.
27. Melsheimer P, Kaul S, Dobeck S, Bastert G: Immunocytochemical detection of HPV high-risk type L1 capsid proteins in LSIL and HSIL as compared with detection of HPV L1 DNA. Acta Cytol 2003; 47: 124-128.
28. Doorbar J: The papillomavirus life cycle. J Clin Virol 2005; 32(suppl 1):S7-S15.
29. Mirabello L, Schiffman M, Ghosh A, Rodriguez AC, Vasiljevic N, Wentzensen N, et al: Elevated methylation of HPV16 DNA is associated with the development of high grade cervical intraepithelial neoplasia. Int J Cancer 2013; 132: 1412-1422.
30. Xi LF, Jiang M, Shen Z, Hulbert A, Zhou XH, Lin YY, et al: Inverse association between methylation of human papillomavirus type 16 DNA and risk of cervical intraepithelial neoplasia grades 2 or 3. PLoS One 2011; 6:e23897.